1. Home
  2. SGHC vs COGT Comparison

SGHC vs COGT Comparison

Compare SGHC & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SGHC

Super Group (SGHC) Limited

HOLD

Current Price

$9.35

Market Cap

5.8B

ML Signal

HOLD

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$35.92

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHC
COGT
Founded
2020
2014
Country
Guernsey
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.5B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SGHC
COGT
Price
$9.35
$35.92
Analyst Decision
Strong Buy
Buy
Analyst Count
6
14
Target Price
$17.67
$32.08
AVG Volume (30 Days)
2.1M
2.4M
Earning Date
02-24-2026
02-24-2026
Dividend Yield
4.33%
N/A
EPS Growth
4925.62
N/A
EPS
0.45
N/A
Revenue
$2,342,912,011.00
N/A
Revenue This Year
$28.42
N/A
Revenue Next Year
$10.86
N/A
P/E Ratio
$20.91
N/A
Revenue Growth
34.94
N/A
52 Week Low
$5.59
$3.72
52 Week High
$14.38
$43.73

Technical Indicators

Market Signals
Indicator
SGHC
COGT
Relative Strength Index (RSI) 32.02 44.23
Support Level $9.58 $36.01
Resistance Level $10.40 $39.65
Average True Range (ATR) 0.43 1.91
MACD -0.01 -0.21
Stochastic Oscillator 9.30 27.30

Price Performance

Historical Comparison
SGHC
COGT

About SGHC Super Group (SGHC) Limited

Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: